Lifetime UVR dose and skin cancer risk, determined by their common relation to solar lentigines

3Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

Background/Aim: Ultraviolet radiation (UVR) causes solar lentigines (SL) and skin cancer (SC) in humans. The association between measured lifetime UVR dose and SC has not been investigated. This study investigated this relation through their common relationship to SL. Materials and Methods: First we investigated the association between lifetime UVR dose and SL for 16,897 days in 38 healthy participants, and secondly, the relation between SL and SC was investigated in 2,898 participants, including 149 with SC. By combining both studies, SC risk related to lifetime UVR dose and skin phototype was estimated. Results: A positive association was found between SL and lifetime UVR dose (p=0.060). Skin phototype (p=0.001) and SL (p<0.001) were associated with SC. Combined SC risk increased 1.23 by doubling the average lifetime UVR dose and was 34.9 times higher for those with very fair skin compared to dark Mediterranean skin. Conclusion: The estimate of SC risk shows that skin phototype is of greater relative importance than lifetime UVR dose.

Cite

CITATION STYLE

APA

Holm-Schou, A. S. S., Philipsen, P. A., Idorn, L. W., Thieden, E., & Wulf, H. C. (2020). Lifetime UVR dose and skin cancer risk, determined by their common relation to solar lentigines. Anticancer Research, 40(1), 557–564. https://doi.org/10.21873/anticanres.13985

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free